MedTrace Logo

Stanford ICU Delirium PIPRA Study

NCT06519890 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 199

Last updated 2024-08-09

No results posted yet for this study

Summary

The purpose of this study is to determine the accuracy of the Pre-Interventional Preventive Risk Assessment (PIPRA) tool in predicting clinical cases of Intensive Care Units (ICU)-delirium, in a population at high risk of developing this syndrome (i.e., admitted patients to Cardiothoracic Intensive Care Units). The population to be studied has already been enrolled in a parallel study intended to determine the accuracy of an electroencephalogram (EEG)-based diagnosis for delirium.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Jose R Maldonado, MD · Stanford University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-30
Primary Completion
2024-07-27
Completion
2024-07-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06519890 on ClinicalTrials.gov